This week, ZenPharm, the Maltese joint venture with Canadian cannabis producer, Zenabis Global, received its Maltese licence to process cannabis for medicinal use and research purposes out of its Hal Far Industrial Estate premises.
Kurt Farrugia, CEO of Malta Enterprise – the national economic development agency that assisted the company to set up locally – considers this “an important milestone for Malta’s medical cannabis industry.”
“We are gaining momentum with the production of cannabis for medical use in Malta,” he wrote. “Zenabis – a Maltese joint venture and partner of Zenpharm, have received a licence for the production of medical cannabis in their facility in Hal Far, Malta.”
The CEO said that the issuing of the second licence for the production of cannabis for medical use shows that “Malta is becoming a centre of excellence in such an important emerging sector.”
“Those companies strive hard to achieve the Medicine’s Authority pharmaceutical standards. Now that they do, patients can rest assured that the Made in Malta product is top quality. A gold standard for the industry. This is indeed a proud moment.”
Through its licence, ZenPharm plans to ship around 500kg of cannabis out of Malta annually to EU countries, with the largest market being Germany.
Featured Image:
Kurt Farrugia / LinkedIn
New hospitality rules ‘delegate policing to private citizens,’ warns Casa Rooms Director
Cecil McCarthy warns that the benefits of any changes are contingent on their consistent enforcement by the authorities.
Paytently appoints Caroline Buhagiar as Director of Finance
She brings over two decades of finance experience.
easyJet Engineering names Melissa Schembri Head of Human Resources
Melissa brings over 15 years’ experience in people strategy and organisational culture.
Stormy winter exposes Gozo ferry vulnerability to climate change, say business groups
Stormy weather caused the number of trips between Malta and Gozo to fall by 9% year-on-year during Q1 2026.
